NGM Biopharmaceuticals raised $90.8M from Tichenor Ventures, Prospect Venture Partners, Rho Capital Partners, The Column Group, Prospect Venture Partners, and Rho Capital Partners in 4 rounds.

NGM raises $13M for cardio/metabolic R&D work    fiercebiotech.com NGM lands $51M for preclinical diabetes work    fiercebiotech.com SEC D    sec.gov

Accera raised $61.6M from POSCO BioVentures, Inventages Venture Capital Investment Inc., and POSCO BioVentures in 5 rounds.

Accera, Inc.: Series D $11M    onbiovc.com Accera raises $35M    fiercebiotech.com SEC D/A    sec.gov SEC D/A    sec.gov SEC D    sec.gov

Elixir Pharmaceuticals raised $58M from MPM Capital, ARCH Venture Partners, Oxford Bioscience Partners, Omega Funds, Physic Ventures, MPM Capital, ARCH Venture Partners, CDIB Ventures, Jafco Ventures, YFY Biotech Management Company, and Oxford Bioscience Partners in 2 rounds.

Elixir Pharmaceuticals, Inc.: Series D $12M    onbiovc.com Elixir raises $46M for fountain of youth    deals.venturebeat.com

Alnara Pharmaceuticals raised $55M from MPM Capital, Bessemer Venture Partners, Third Rock Ventures, and Frazier Healthcare Ventures in 2 rounds.

http://www.fiercebiotech.com/story/alnara-grabs-35m-vc-cash-it-aims-nda/2010-01-28?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0    fiercebiotech.com Alnara Pharmaceuticals Inc Obtains $20,000,000 Series A Round    xconomy.com

Marinus Pharmaceuticals raised $41M from Domain Associates, Canaan Partners, Sofinnova Ventures, Foundation Medical Partners, Canaan Partners, Domain Associates, Sofinnova Ventures, and Foundation Medical Partners in 2 rounds.

Marinus Pharmaceuticals Raises $21M Funding in Series C Financing    finsmes.com Marinus Pharmaceuticals, Inc.: Series B $20M    onbiovc.com

Quark Pharmaceuticals raised $27M from SBI Asset Management and SBI Investment .